ALLR vs. QNTM, AFMD, SLGL, SPRB, SYBX, GOVX, NRSN, BMRA, EGRX, and HCWB
Should you be buying Allarity Therapeutics stock or one of its competitors? The main competitors of Allarity Therapeutics include Quantum Biopharma (QNTM), Affimed (AFMD), Sol-Gel Technologies (SLGL), Spruce Biosciences (SPRB), Synlogic (SYBX), GeoVax Labs (GOVX), NeuroSense Therapeutics (NRSN), Biomerica (BMRA), Eagle Pharmaceuticals (EGRX), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical products" industry.
Allarity Therapeutics vs.
Quantum Biopharma (NASDAQ:QNTM) and Allarity Therapeutics (NASDAQ:ALLR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.
In the previous week, Quantum Biopharma and Quantum Biopharma both had 1 articles in the media. Quantum Biopharma's average media sentiment score of 0.00 beat Allarity Therapeutics' score of -0.31 indicating that Quantum Biopharma is being referred to more favorably in the media.
1.2% of Quantum Biopharma shares are owned by institutional investors. Comparatively, 11.5% of Allarity Therapeutics shares are owned by institutional investors. 8.5% of Quantum Biopharma shares are owned by insiders. Comparatively, 0.1% of Allarity Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Quantum Biopharma has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, Allarity Therapeutics has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500.
Allarity Therapeutics received 1 more outperform votes than Quantum Biopharma when rated by MarketBeat users.
Quantum Biopharma's return on equity of -84.21% beat Allarity Therapeutics' return on equity.
Summary
Quantum Biopharma beats Allarity Therapeutics on 5 of the 8 factors compared between the two stocks.
Get Allarity Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALLR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Allarity Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:ALLR) was last updated on 2/22/2025 by MarketBeat.com Staff
